KEYTRUDA 25 mg/mL concentrate for solution for infusion, DOMVANALIMAB, AB122 (Zimberelimab)
ARC-10
Phase 3 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, DOMVANALIMAB, AB122 (Zimberelimab) for Squamous Non-small cell Lung Cancer, Non-Small Cell Lung Cancer, Non squamous Non Small Cell Lung Cancer, Lung Cancer is a Phase 3 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Squamous Non-small cell Lung Cancer, Non-Small Cell Lung Cancer, Non squamous Non Small Cell Lung Cancer, Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active